2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG) positron emission tomography for the diagnosis and treatment of Burkitt lymphoma

@article{Alexander2013218Ffluoro2deoxyDglucoseP,
  title={2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG) positron emission tomography for the diagnosis and treatment of Burkitt lymphoma},
  author={Mohab Alexander and James Robert Bra{\vs}i{\'c}},
  journal={Journal of Biomedical Graphics and Computing},
  year={2013},
  volume={3},
  pages={67}
}
Background/Objective: Burkitt lymphoma, a form of non Hodgkin lymphoma, is a rare aggressive mature B-cell neoplasm with a favorable prognosis. The objective of this article is to demonstrate that the prompt diagnosis and the application of effective treatments of Burkitt lymphoma is facilitated by the efficacious use of 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography. Case Report: A 45-year-old man presented with pain in and around his joints and his bones. After multiple… Expand
1 Citations
The role of lumateperone in the treatment of schizophrenia
TLDR
A critical evaluation of the limited information about lumateperone for schizophrenia, its use approved by the US Food and Drug Administration and its consideration for patients with treatment-resistant schizophrenia is presented. Expand

References

SHOWING 1-10 OF 27 REFERENCES
Molecular imaging of proliferation in malignant lymphoma.
TLDR
Due to specific imaging of proliferation, FLT may be a superior PET tracer for detection of malignant lymphoma in organs with high physiologic fluorodeoxyglucose uptake and early detection of progression to a more aggressive histology or potential transformation. Expand
Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma.
  • H. Schöder, A. Noy, +5 authors H. Yeung
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2005
TLDR
FDG uptake is lower in indolent than in aggressive lymphoma, and patients with NHL and SUV > 10 have a high likelihood for aggressive disease. Expand
[18F]FDG PET monitoring of tumour response to chemotherapy: does [18F]FDG uptake correlate with the viable tumour cell fraction?
TLDR
In contrast with variations in tumour volume, [18F]FDG is a good marker for chemotherapy response monitoring, however, optimal timing seems crucial since a transient increase in stromal reaction may result in overestimation of the fraction of viable cells. Expand
18F-FDG PET and PET/CT in Burkitt's lymphoma.
TLDR
FDG PET-PET/CT is sensitive for the detection of viable disease in Burkitt's lymphoma and affected areas demonstrated high degree of uptake that was reversible upon successful implementation of treatment. Expand
Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients
  • L. Strauss
  • Medicine
  • European Journal of Nuclear Medicine
  • 2005
TLDR
It is concluded that an iterative image reconstruction method is to be favoured, given its advantages in reducing image artefacts and improving quantification of radioactivity concentrations. Expand
American Burkitt's lymphoma of the head and neck: evaluation with serial FDG-PET.
F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) is known to be a noninvasive, safe, and useful diagnostic tool for staging, restaging, and follow up of neoplastic disease. ThisExpand
Staging of Burkitt's lymphoma and response to treatment monitored by PET scanning.
TLDR
This case report demonstrates that clinical PET scanning can be especially useful in staging patients with lymphoma in whom there is extensive extranodal and marrow involvement, and that PET can follow changes in tumour viability over a very short time span. Expand
Durable remission induced by rituximab-containing chemotherapy in a patient with primary refractory Burkitt's lymphoma
TLDR
A dramatic clinical improvement was observed and abnormal uptake by 18F-fluorodeoxyglucose positron emission tomography disappeared, indicating that rituximab might be an important treatment choice in management of Burkitt's lymphoma. Expand
Primary effusion Burkitt's lymphoma with t(8;22) in a patient with hepatitis C virus-related cirrhosis.
TLDR
The finding of HCV-RNA in the ascitic fluid suggests a link between HCV and development of lymphoma with HCV playing the role of persistent antigenic stimulation to intraperitoneal B-cell clonal expansion(s). Expand
Myocardial involvement in a patient with Burkitt's lymphoma mimicking hypertrophic cardiomyopathy.
  • J. Bergler-Klein, P. Knoebl, +5 authors T. Binder
  • Medicine
  • Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography
  • 2003
TLDR
The case of a young woman with generalized Burkitt's lymphoma, initially presenting with signs and symptoms of central nervous system involvement, resolved after high-intensity chemotherapy with a modified B-cell acute lymphoblastic leukemia (B-ALL) protocol. Expand
...
1
2
3
...